KYH
DEAD

Serial Number

79375791

Owner

KWALATA TRADING LIMITED

Filing Date

Mar 10, 2023

Add to watchlist:

No watchlists yet
View on USPTO

KYH Trademark

Serial Number: 79375791

KYH is a trademark filed by KWALATA TRADING LIMITED on March 10, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

KWALATA TRADING LIMITED (7 trademarks)

P.O. BOX 22454
NICOSIA 1522 , CY

Entity Type: 03

Trademark Details

Filing Date

March 10, 2023

Registration Date

Not Registered

Goods & Services

Stem cell preparations used for the treatment of peripheral neuropathy, peripheral vascular disease, critical limb ischemia, wound care, Class 1 - IV (end stage) heart diseases, angina pectoris, ischemic and dilated cardiomyopathy, COPD, idiopathic pulmonary hypertension and other diseases of ischemia; biomedical autologous and allogenic preparations used for the treatment of minor health disorders to prevent them from becoming severe health disorders, and to treat severe health disorders on an ongoing basis to slow, eliminate, or reverse their progress

Stem cell preparations used for research of peripheral neuropathy, peripheral vascular disease, critical limb ischemia, wound care, Class 1 - IV (end stage) heart diseases, angina pectoris, ischemic and dilated cardiomyopathy, COPD, idiopathic pulmonary hypertension and other diseases of ischemia; biomedical autologous and allogenic preparations used for research, other experiments of minor health disorders to prevent them from becoming severe health disorders

Services in the medical field, namely, extracting, processing, culturing, testing, injecting or administering under medical supervision the products derived from blood and blood components; services in the medical field, namely, selecting, processing, manipulating, purging and storing stem cells from blood and adding regenerative cells to the body

Research and development in the field of blood, blood products and blood testing; scientific research services in the field of blood and stem cells

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 1, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 1, 2025 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
May 30, 2024 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
May 30, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 30, 2024 ABN2
REFUSAL PROCESSED BY IB
Dec 4, 2023 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 16, 2023 RFCS
REFUSAL PROCESSED BY MPU
Nov 15, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 14, 2023 RFCR
NON-FINAL ACTION WRITTEN
Nov 13, 2023 CNRT
ASSIGNED TO EXAMINER
Nov 9, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 11, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 7, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 4, 2023 REPR